/

Companies / Tafalgie Therapeutics

Tafalgie Therapeutics

Marseille, FRANCE, France

Tafalgie Therapeutics is a clinical-stage biotechnology company specializing in the development of next-generation painkillers

Its latest round on record is Series A, 15 Sept 2025. Its site was last checked 20 Nov 2026: site answers.

Funding

1 round on record
Latest roundSeries A15 Sept 2025
Since that round1 year 2 monthsno later round on record
Sept 2025Series AInvestors not named

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

none on file yet

No investor VCinfo tracks lists Tafalgie Therapeutics yet.

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Tafalgie Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when an investor you follow adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/tafalgie.fr/investors

# also
GET /v1/companies/tafalgie.fr
GET /v1/companies/tafalgie.fr/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing